| __timestamp | Bristol-Myers Squibb Company | Veracyte, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4534000000 | 9804000 |
| Thursday, January 1, 2015 | 5920000000 | 12796000 |
| Friday, January 1, 2016 | 4940000000 | 15324000 |
| Sunday, January 1, 2017 | 6411000000 | 13881000 |
| Monday, January 1, 2018 | 6345000000 | 14820000 |
| Tuesday, January 1, 2019 | 6148000000 | 14851000 |
| Wednesday, January 1, 2020 | 11143000000 | 17204000 |
| Friday, January 1, 2021 | 10195000000 | 29843000 |
| Saturday, January 1, 2022 | 9509000000 | 40603000 |
| Sunday, January 1, 2023 | 9299000000 | 57305000 |
| Monday, January 1, 2024 | 11159000000 |
In pursuit of knowledge
In the competitive world of pharmaceuticals and biotechnology, research and development (R&D) spending is a critical indicator of innovation and future growth. Over the past decade, Bristol-Myers Squibb Company and Veracyte, Inc. have demonstrated contrasting trajectories in their R&D investments.
From 2014 to 2023, Bristol-Myers Squibb's R&D expenses surged by over 100%, peaking in 2020 with a remarkable 11 billion dollars. This reflects their commitment to maintaining a leading edge in the pharmaceutical industry. In contrast, Veracyte, Inc., a smaller player in the biotech field, increased its R&D spending by nearly 500% during the same period, albeit from a much smaller base. By 2023, Veracyte's R&D expenses reached approximately 57 million dollars, showcasing their aggressive push towards innovation.
This data highlights the diverse strategies of established giants and emerging innovators in the healthcare sector.
Who Prioritizes Innovation? R&D Spending Compared for Amgen Inc. and Bristol-Myers Squibb Company
Bristol-Myers Squibb Company vs Gilead Sciences, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Bristol-Myers Squibb Company and Zoetis Inc. Allocate Funds
Bristol-Myers Squibb Company or BeiGene, Ltd.: Who Invests More in Innovation?
Comparing Innovation Spending: Bristol-Myers Squibb Company and Dr. Reddy's Laboratories Limited
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Alkermes plc
Comparing Innovation Spending: Bristol-Myers Squibb Company and Catalyst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Corcept Therapeutics Incorporated and Veracyte, Inc.
Analyzing R&D Budgets: Veracyte, Inc. vs Bausch Health Companies Inc.
Veracyte, Inc. or Wave Life Sciences Ltd.: Who Invests More in Innovation?
Analyzing R&D Budgets: Veracyte, Inc. vs Novavax, Inc.
R&D Insights: How Veracyte, Inc. and Taro Pharmaceutical Industries Ltd. Allocate Funds